LOW DOSE IL-2 CIRCUMVENTED MTOR SIGNALING IN T CELLS IN THE TREATMENT OF SLE

被引：0
|
作者：
He, J. [1 ]
Sun, X. [1 ]
Li, J. [1 ]
Zhang, R. [1 ]
Yu, D. [2 ]
Li, Z. [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Monash Univ, Sch Biomed Sci, Melbourne, Vic, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3482
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0141
引用
收藏
页码：1096 / 1096
页数：1
相关论文
共 50 条
  • [21] The rise of IL-2 therapy — a novel biologic treatment for SLE
    Jens Y. Humrich
    Gabriela Riemekasten
    Nature Reviews Rheumatology, 2016, 12 : 695 - 696
  • [22] The rise of IL-2 therapy - a novel biologic treatment for SLE
    Humrich, Jens Y.
    Riemekasten, Gabriela
    Nature Reviews Rheumatology, 2016, 12 (12) : 695 - U72
  • [23] Low-Dose IL-2 Treatment Affords Protection against Subarachnoid Hemorrhage Injury by Expanding Peripheral Regulatory T Cells
    Dong, Guoping
    Li, Cong
    Hu, Quan
    Wang, Yuan
    Sun, Jingyi
    Gao, Feng
    Yang, Mingfeng
    Sun, Baoliang
    Mao, Leilei
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (03): : 430 - 440
  • [24] Blimp-1 is a negative regulator of IL-2 signaling in T cells
    Roy, Suyasha
    Ren, Min
    Christensen, Steve
    Li, Peng
    Spolski, Rosanne
    Phelan, James
    Staudt, Louis
    Leonard, Warren J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [25] Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle
    Yarkoni, Shai
    Kaminitz, Ayelet
    Sagiv, Yuval
    Yaniv, Isaac
    Askenasy, Nadir
    BIOESSAYS, 2008, 30 (09) : 875 - 888
  • [26] Low-dose IL-2 in the treatment of immune-related diseases
    Zhang, Jiakui
    Huang, Yong
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [27] Immunotherapy combining allergen with low-dose IL-2 to generate antigen specific regulatory T cells
    Moguel, Helena
    Vigneron, James
    Gouritin, Bruno
    Vantomme, Helene
    Klatzmann, David
    Bellier, Bertrand
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 387 - 387
  • [28] LOW-DOSE IL-2 SELECTIVELY RESTORES REGULATORY T CELLS IN PATIENTS WITH BEHCET'S DISEASE
    Liu, Xiaoqing
    Chai, Gaiqin
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 252 - 252
  • [29] LOW-DOSE IL-2 THERAPY SELECTIVELY EXPANDS REGULATORY T CELLS AND SUPPRESSES MURINE LUPUS
    Humrich, J. Y.
    Kloke, L.
    Rose, A.
    von Spee, C.
    Klaus, A.
    Undeutsch, R.
    Riemekasten, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 527 - 527
  • [30] Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
    Haotian Zhou
    Xiaozhen Zhao
    Ruijun Zhang
    Miao Miao
    Wenwen Pei
    Zijun Li
    Yimin Li
    Jing He
    Zhanguo Li
    Xiaolin Sun
    Signal Transduction and Targeted Therapy, 8
12345